https://scholars.lib.ntu.edu.tw/handle/123456789/633540
標題: | Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Primary results from PALOMA-4 | 作者: | Xu, Binghe Hu, Xichun Li, Wei Sun, Tao Shen, Kunwei Wang, Shusen Cheng, Ying Zhang, Qingyuan Cui, Shude Tong, Zhongsheng Geng, Cuizhi Song, Erwei CHIUN-SHENG HUANG et al., |
關鍵字: | Advanced breast cancer; Asian; Letrozole; Oestrogen receptor–positive; Palbociclib | 公開日期: | 十一月-2022 | 卷: | 175 | 來源出版物: | European journal of cancer (Oxford, England : 1990) | 摘要: | The cyclin-dependent kinase 4/6 inhibitor palbociclib has demonstrated efficacy and a manageable safety profile in combination with endocrine therapy in women with oestrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) in international phase 3 trials. The phase 3 PALOMA-4 trial evaluated the efficacy and safety of palbociclib plus letrozole versus placebo plus letrozole in Asian women with ER+/HER2- ABC. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/633540 | ISSN: | 09598049 | DOI: | 10.1016/j.ejca.2022.08.012 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。